Bone Marrow Multipotent Mesenchymal Stromal Cells as Autologous Therapy for Osteonecrosis: Effects of Age and Underlying Causes

Bone marrow (BM) is a reliable source of multipotent mesenchymal stromal cells (MSCs), which have been successfully used for treating osteonecrosis. Considering the functional advantages of BM-MSCs as bone and cartilage reparatory cells and supporting angiogenesis, several donor-related factors are...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jehan J El-Jawhari, Payal Ganguly, Elena Jones, Peter V Giannoudis
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2021-05-01
coleção:	Bioengineering
Assuntos:	multipotent mesenchymal stromal cells osteonecrosis autologous bone marrow regenerative therapy
Acesso em linha:	https://www.mdpi.com/2306-5354/8/5/69
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!